Cost-Effectiveness of Atrial Fibrillation Screening Strategies: A Systematic Review

Atrial fibrillation (AF) is the most common cardiac arrhythmia. AF is associated with an in-creased risk of stroke. We aimed to review systematically the cost-effectiveness of screening strategies for pa-tients with AF.

To find related research and articles, articles published in Iranian and international databases by us-ing a combination of MeSH (Medical Subject Headings) terms and based on inclusion and exclusion criteria were searched and revieweduntil Dec 2020. The main outcome measures of the final articles were incremental cost-effectiveness ratios (ICER) per gained or additional quality-adjusted life years (QALYs), additional case detected, and avoided stroke.

Out of 3,360 studies found, finally, fifteen studies were included in the research. The lowest ICER numerical value was 78.39 for AF screening using ECG for 65-85 yr old Japanese women. The highest value of this index is equal to 70864.31 for performing ECG monitoring for more than 60 d for Canadians over 80 yr without AF history. In two studies, the results were expressed with the years of life gained (YLG measure. Of course, in one study, the results were not reported with this measure, and in one study, the results were report-ed with ICER.

Most of the studies acknowledged the cost-effectiveness of different AF screening strategies. However, studies that confirmed the cost-effectiveness of population-based screening were more than studies that confirmed the cost-effectiveness of other screening strategies.